May 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountallozyne.com
Global Rank
- -
Country Rank
- -
Category Rank
- -
Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
- Company
- - -
- Industry
- - -
Top 10 allozyne.com Competitors
The Top 10 Sites Like allozyne.com in May 2026 are ranked by their affinity to allozyne.com in terms of keyword traffic, audience targeting, and market overlap
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%[...]Read More... from DT-X AMS Automated Monitoring System
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
38.47%
Pages per Visit
1.10
Avg Visit Duration
- -
Similarity Score
100%- Company
- Insilicos
- Industry
- Science and Education > Biology
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
68.51%
Pages per Visit
1.34
Avg Visit Duration
00:01:01
Similarity Score
100%theraclone sciences / capturing the native human antibody repertoire to clinically relevant antigens
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%– Initial Clinical Data Expected in First Half of 2020 – AUBURN, WASHINGTON — Syntrix Pharmaceuticals today announced that it has dosed the first patient in its Phase 1/2 clinical trial that will combine SX-682 with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy. SX-682 is an oral dual inhibitor of CXCR1 and CXCR2 (CXCR1/2) being developed for
- Company
- - -
- Industry
- - -
Bounce Rate
35.75%
Pages per Visit
2.02
Avg Visit Duration
00:00:46
Similarity Score
100%Mainkan Slot Mahjong Ways 2 di Winlose99! Situs slot gacor hari ini dengan fitur x500, RTP transparan & jaminan bayar lunas. Daftar & raih maxwin!.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
- Company
- ZymoGenetics
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%allozyne.com's top 5 competitors in May 2026 are: acceleratorcorp.com, biosonicsinc.com, insilicos.com, istartsurf.com, and more.
According to Similarweb data of monthly visits, allozyne.com’s top competitor in May 2026 is acceleratorcorp.com. allozyne.com 2nd most similar site is biosonicsinc.com, and closing off the top 3 is insilicos.com.
istartsurf.com ranks as the 4th most similar website to allozyne.com and spaltudaq.com ranks fifth in May 2026.
The other five competitors in the top 10 list are syntrixbio.com, vlstcorp.com, zymogenetics.com, , and .